Ireland· IE-PA-EU/1/17/1208/010-012
Trimbow 88 micrograms/5 micrograms/9 micrograms inhalation powder
A formoterol, glycopyrronium bromid und beclometason product containing beclometasone dipropionate + formoterol fumarate dihydrate + glycopyrronium + glycopyrronium bromide, registered in Ireland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Formoterol, glycopyrronium bromid und beclometason is registered in 10 of 19 countries.
Countries holding a registration under ATC R03AL09 (formoterol, glycopyrronium bromid und beclometason), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Formoterol, glycopyrronium bromid und beclometason · ATC R03AL09
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Beclometasone dipropionate + Formoterol fumarate dihydrate + GLYCOPYRRONIUM + Glycopyrronium bromide
- Manufacturer
- Chiesi Farmaceutici S.p.A.
- Country
- Ireland (IE)
- ATC code
- R03AL09
- ATC class
- Formoterol, Glycopyrronium bromid und Beclometason
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/17/1208/010-012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R03AL09
Formoterol, glycopyrronium bromid und beclometason, as other registers publish it.
- FinlandRiarifyChiesi Farmaceutici S.p.A.
- PolandRiarifyChiesi Farmaceutici S.p.A.
- DenmarkRiarifyChiesi Farmaceutici S.p.a.
- BelgiumRiarify 87 µg/dose - 5 µg/dose - 9 µg/doseChiesi Farmaceutici
- FinlandTrimbowOrifarm Oy
- FinlandTrimbowChiesi Farmaceutici S.p.A.
- FinlandTrimbowChiesi Farmaceutici S.p.A.
- IcelandTrimbowChiesi Farmaceutici S.p.A.*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf5d1b2c-8ed0-4c88-9fe9-e8aabd28fa24 GET /v1/drugs/bf5d1b2c-8ed0-4c88-9fe9-e8aabd28fa24?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalation powder",
"routes": [
"Inhalation use"
],
"source": "hpra",
"atc_all": [
"R03AL09"
],
"strength": null,
"pa_number": "EU/1/17/1208/010-012",
"substances": [
"Beclometasone dipropionate",
"Formoterol fumarate dihydrate",
"GLYCOPYRRONIUM",
"Glycopyrronium bromide"
],
"legal_basis": "Fixed combination application (Article 10b of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "17/07/2017",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about formoterol, glycopyrronium bromid und beclometason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.